N@N

Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults

_{//health-fitness.news-articles.net/content/2010/ .. ment-of-major-depressive-disorder-in-adults.html}
^{Published in Health and Fitness on Tuesday, August 10th 2010 at 6:10 GMT by Market Wire}  

 ------------------------------------------------------------------------- WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS See full prescribing information for complete boxed warning. Increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Oleptro(TM) is not approved for use in pediatric patients. ------------------------------------------------------------------------- 

 ----------------------------- (i) Bostwick, J.M., A Generalist's Guide to Treating Patients with Depression with an Emphasis on Using Side Effects to Tailor Antidepressant Therapy. Mayo Clin Proc. 2010;85(6):538-550 (ii) Lin E.H. et al. Medcare.1995;33:67-74